Scott, Alex
April 2004
Chemical Week;4/21/2004, Vol. 166 Issue 13, p23
Trade Publication
Looks at the growth of Syngenta, a company formed via the merger of the agricultural chemical businesses of Novartis and AstraZeneca in 2000, as of April 21, 2004. Financial performance of the company; Main businesses of Syngenta; Actions taken by the company to expand its seeds business; Decline in the firm's research and development costs.


Related Articles

  • Syngenta Parents Plan $1-Billion Share Buyback Scheme. Bown, Jessica // Chemical Week;9/27/2000, Vol. 163 Issue 36, p23 

    Reports on a $1-billion buyback program planned by Novartis and AstraZeneca to support the share price of Syngenta, which will be formed from the merger of their agricultural chemicals businesses. Aim of the buyback program; Expected annual sales of Syngenta; Terms under the program; Annual...

  • A profile of Syngenta. Moore, Mark // Farm Industry News;Dec2011, Vol. 44 Issue 11, p40 

    The article features Syngenta, an agricultural chemical company with headquarters in Basel, Switzerland. Created in late 2000 with the merger of the agribusiness of Novartis and AstraZeneca, the parent company of Syngenta traces its roots to Geigy, formed in 1758. Its core business, comprised of...

  • Syngenta Merger in Sight. Bown, Jessica // Chemical Week;8/9/2000, Vol. 162 Issue 30, p19 

    Focuses on the possible completion of Syngenta, company formed through the merger of pesticide businesses of AstraZeneca company and Novartis company.

  • Syngenta Aims to Expand its Agchems Position. Cage, Sam // Chemical Week;11/6/2002, Vol. 164 Issue 44, p39 

    Presents updates on Syngenta chemical company as of November 6, 2002. Plan to expand its market position in agricultural chemicals; Flat crop protection sales; Information on the merger of the pesticides businesses of Novartis firm and AstraZeneca firm with Syngenta.

  • Novartis and AstraZeneca Plan Share Buyback for Syngenta. Milmo, Sean // Chemical Market Reporter;09/25/2000, Vol. 258 Issue 13, p8 

    Deals with the plan of Novartis and AstraZeneca to provide share capital to enable Syngenta to launch a share buyback. Reason for a buyback; Information on Syngenta.

  • Syngenta Shares Receive a Low Valuation. Milmo, Sean // Chemical Market Reporter;11/06/2000, Vol. 258 Issue 19, p8 

    Reports that shares in Syngenta, the crop protection company to be floated by its parent companies Novartis and AstraZeneca, have been given a listing valuation well below the rate estimated. Price range of the shares; Views on the valuation of the flotation.

  • AstraZeneca, Novartis to Combine Agchem Units. Scott, Alex // Chemical Week;12/8/1999, Vol. 161 Issue 47, p13 

    Reports on the plans of AstraZeneca and Novartis to combine and spin off their agrichem businesses. Name of the combined company; Estimated share of Syngenta in the global pesticides market; Terms under the agreement.

  • SWOT Analysis.  // Syngenta AG SWOT Analysis;Sep2007, p5 

    A business analysis of Syngenta AG, one of the world's leading agrochemical and seeds companies, is provided, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company. Strengths include strong research and development. Weaknesses include low returns....

  • Europe Watch. Gibson, Jane // ICIS Chemical Business;10/30/2006, Vol. 1 Issue 41, p10 

    The article presents news briefs on the financial performance of European chemical companies for the third quarter (Q3) of 2006. Syngenta's Q3 sales climbed 1% to $1.41bn. The refining and marketing business of BP suffered a 25% decrease in year-on-year Q3 replacement cost-operating profits to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics